SUBSCRIPTION AGREEMENTSubscription Agreement • December 8th, 2008 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 8th, 2008 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of December 4, 2008, by and among ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investors (together with their successors and permitted assigns, the “Investors” and each an “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 11.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • April 5th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 5th, 2007 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of April 5, 2007 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • April 5th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 5th, 2007 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of March 30, 2007 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • March 8th, 2007 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 8th, 2007 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of March 2, 2007 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • December 6th, 2006 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 6th, 2006 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of December 1, 2006 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • December 6th, 2006 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 6th, 2006 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of November 30, 2006 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.
SUBSCRIPTION AGREEMENTSubscription Agreement • July 18th, 2005 • Regen Biologics Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 18th, 2005 Company Industry JurisdictionThis Subscription Agreement (this “Agreement”) is entered into as of July 14, 2005 by and between ReGen Biologics, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Issuer”), and the undersigned investor (together with its successors and permitted assigns, the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in Section 9.1.